Value & Innovation First Alzheimer’s Agitation Drug Could Help Patients, Caregivers May 30, 2023 Blog
Patient Access Fight Continues to Expand Federal Benefits for Huntington’s Disease April 18, 2023 Blog
Value & Innovation FDA Grants Priority Review to Drug for Depressive Disorders February 23, 2023 Blog
